What was lobbied
21 issue areas, each in the filer's own words, with who lobbied on it and where.
Contacted: U.S. Trade Representative (USTR); Energy, Dept of; State, Dept of (DOS); Treasury, Dept of; Health Resources & Services Administration (HRSA); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); SENATE; Congressional Budget Office (CBO); Office of Science & Technology Policy (OSTP); Centers For Disease Control & Prevention (CDC); White House Office; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Small Business Administration (SBA); Food & Drug Administration (FDA); Natl Institutes of Health (NIH)
Adventitious Presence Release of USDA's Precursor to APHIS 340 Regs Livestock Cloning Draft FDA Animal Cloning Risk Assessment Proposed FDA Risk Management Plan Draft FDA Guidance for Industry USDA National Organic Standards Board Cloning Recommendation Regulation of Transgenic Animals Development of FDA Guidance and Advance Notice of Proposed Rulemaking Application of Federal Insecticide Fungicide and Rodenticide Act (FIFRA) regulations to biotech plants
Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE; U.S. Trade Representative (USTR); State, Dept of (DOS); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Energy, Dept of; Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Centers For Disease Control & Prevention (CDC); Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Treasury, Dept of; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); White House Office; Small Business Administration (SBA); Securities & Exchange Commission (SEC)
Sarbanes-Oxley Section 404 Reform
Contacted: Natl Institutes of Health (NIH); White House Office; Congressional Budget Office (CBO); Commerce, Dept of (DOC); State, Dept of (DOS); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Treasury, Dept of; Small Business Administration (SBA); Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); SENATE; Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Energy, Dept of; U.S. Trade Representative (USTR)
Contacted: Centers For Disease Control & Prevention (CDC); Congressional Budget Office (CBO); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Small Business Administration (SBA); Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); State, Dept of (DOS); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); White House Office; Office of Management & Budget (OMB); Energy, Dept of; SENATE; Treasury, Dept of
Biotech Tax Package H.R. 3264: American Life Sciences Competitiveness Act of 2007 Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Engery Conservation Tax Act of 2007 R&D Tax Credit H.R. 2138: Investment in America Act of 2007 Cross Licensing Agreement Taxation Treasury Department Proposal
Contacted: U.S. Trade Representative (USTR); White House Office; Treasury, Dept of; Small Business Administration (SBA); Congressional Budget Office (CBO); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); SENATE; Commerce, Dept of (DOC); Energy, Dept of; Natl Institutes of Health (NIH); Patent & Trademark Office (PTO)
Bills named:
H.R. 3264 (110th), H.R. 2138 (110th), S. 1618 (110th)
Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Energy and Water Development and Related Agencies Appropriations Act, FY 2008 S. 1751: Energy and Water Development Appropriations Act, FY 2008 H.J.Res 20: Revised Continuing Appropriations Resolution, 2007 Adventitious Presence Release of USDA's Precursor to APHIS 340 Regs Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement U.S. Malaysia Free Trade Agreement U.S. Russia World Trade Organization Accession Negotiations India Agricultural Biotechnology Regulations China Biotechnology Regulations Mexico Biotech Regulations International Policy Regarding Agricultural Biotechnology U.S. Government Negotiation Position World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings Codex Biotechnology Agenda U.S. Government Food Standards Negotiations USDA Agriculture Biotechnology Regulations USDA Biotechnology Policies Federal Preemption Oversight of Industry Exports of Agricultural Biotechnology Products Agricultural Biotechnology Stewardship 2007 Farm Bill Animal Welfare Biofuels/Energy Research Preemption Application of Federal Insecticide Fungicide and Rodenticide Act (FIFRA) regulations to biotech plants Funding for Biotechnology Regulatory Services/USDA FY 2008 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act Cartagena Biosafety Protocol Implementation and Effect on Agricultural Biotechnology Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Energy Conservation Tax Act of 2007 Biorefinery Programs H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007
Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Energy, Dept of; Office of Science & Technology Policy (OSTP); White House Office; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Small Business Administration (SBA); Congressional Budget Office (CBO); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); SENATE; Treasury, Dept of
Bills named:
S. 1751 (110th), H.R. 2641 (110th), S. 1618 (110th), H.J.Res. 20 (110th), H.R. 6 (110th)
Codex Biotechnology Agenda U.S. Government Food Standards Negotiations Foreign Agricultural Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement U.S. Malaysia Free Trade Agreement U.S. Russia World Trade Organization Accession Negotiations India Agricultural Biotechnology Regulations China Biotechnology Regulations Mexico Biotech Regulations International Policy Regarding Agricultural Biotechnology U.S. Government Negotiation Positions World Trade Organization on EU Biotech Moratorium U.S. Government Dispute Settlement Proceedings USDA Agriculture Biotechnology Regulations USDA Biotechnology Policies Federal Preemption Oversight of Industry Exports of Agricultural Biotechnology Products Agricultural Biotechnology Stewardship Cartagena Biosafety Protocol Implementation and Effect on Agricultural Biotechnology CBD TRIPS Amendment Genetic Origin Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Intellectual Property Protections as Part of Panama and Peru Free Trade Agreements International Intellectual Property Enforcement Bill ITC Exclusion Orders - Impact on Biotechnology ITC Remedy Qualcomm Case
Contacted: SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Small Business Administration (SBA); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Office of Management & Budget (OMB); Congressional Budget Office (CBO); Treasury, Dept of; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); White House Office; Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Energy, Dept of
Genetic Information Nondiscrimination S. 358 H.R. 493
Contacted: Energy, Dept of; Environmental Protection Agency (EPA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Treasury, Dept of; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); White House Office; Office of Science & Technology Policy (OSTP)
Bills named:
H.R. 493 (110th), S. 358 (110th)
Patent Reform H.R. 1908: Patent Reform Act of 2007 S. 1145: Patent Reform Act of 2007 Bayh-Dole Act PTO Proposed Regulations Continuation Rules: FR 2005-P-066 Claims Rules: FR 2005-P-067 Information Disclosure Rules: 71 FR 38808 CBD TRIPS Amendment Genetic Origin Disclosure Requirements Intellectual Property and Access to Medicines for Neglected Diseases and Diseases of Developing World Intellectual Property Protections as Part of Panama and Peru Free Trade Agreements International Intellectual Property Enforcement Bill ITC Exclusion Orders - Impact on Biotechnology ITC Remedy Qualcomm Case Substantive Patent Law Harmonization U.S. Government Negotiation Positions Gene Patenting H.R. 977: A bill to prohibit gene patents
Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Congressional Budget Office (CBO); SENATE; White House Office; Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Small Business Administration (SBA); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC); Treasury, Dept of; State, Dept of (DOS); Securities & Exchange Commission (SEC); Energy, Dept of; U.S. Trade Representative (USTR); Health Resources & Services Administration (HRSA)
Bills named:
H.R. 977 (110th), S. 1145 (110th), H.R. 1908 (110th)
Drug Safety H.R. 2900: FDA Administration Amendments Act of 2007 (FDAAA) S.1082: FDA Revitalization Act (FDARA) Follow-on Biologics H.R. 1956: Patient Protection and Innovative Biologic Medicines Act S. 6237: Access to Life-Saving Medicines Act H.R. 1038: Access to Lifesaving Medicines Act S.1695: Biologics Price Competition and Innovation Act of 2007 Medicaid Expansion/Rebates H.R. 3162: The Children's Health and Medicare Protection Act of 2007 S.1893: The Children's Health Insurance Program Reauthorization Act of 2007 Medicare Clinical Trial Coverage Policy Implementation of Medicare Clinical Research Policy National Coverage Decision Comparative Effectiveness Research Initiatives S.3: Medicare Prescription Drug Price Negotiation Act of 2007 Medicare Part D "Non-Interference" Proposals S.250 and H.R. 4: Medicare Prescription Drug Price Negotiation Act FDA Appropriations Critical Path; Drug Safety; Human Drug Review Funding for Pandemic Influenza FY 2007 Emergency Supplemental Budget FY 2008 Budget H.R. 3043:Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biodefense Advanced R&D (BARDA) FY 2007 Emergency Supplemental Budget FY 2008 Budget S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Approp. Act, FY 2008 Funding for National Institutes of Health S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 340B of the Public Health Service Act/Drug Prices for Covered Entities Administrative Interpretations of Pricing Calculations Guidance on Calculation of 340B Ceiling Price Genetic Information Nondiscrimination S. 358 H.R. 493 Drug Importation S.1082: FDA Revitalization Act (FDARA) Biodefense Implementation Plan and Strategic Plan HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Vaccines for Children Contract Data Availability Request
Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); White House Office; HOUSE OF REPRESENTATIVES; Treasury, Dept of; Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Small Business Administration (SBA); State, Dept of (DOS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Energy, Dept of; SENATE; Natl Institutes of Health (NIH); Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA)
Bills named:
S. 358 (110th), S. 1710 (110th), S. 6237 (110th), S. 1893 (110th), H.R. 4 (110th), S. 1695 (110th), H.R. 1956 (110th), S. 1082 (110th), S. 250 (110th), H.R. 3162 (110th), H.R. 493 (110th), H.R. 2900 (110th), S. 3 (110th), H.R. 1038 (110th), H.R. 3043 (110th)
Sarbanes-Oxley Section 404 Reform Small Business Innovation Research (SBIR) Funding
Contacted: Small Business Administration (SBA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Energy, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); SENATE; Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Treasury, Dept of; Natl Institutes of Health (NIH); White House Office; Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO)
Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Engery Conservation Tax Act of 2007 R&D Tax Credit H.R. 2138: Investment in America Act of 2007 Renewable Fuels Standard S. 1297: Advanced Clean Fuels Act S. 1324: National Low-Carbon Fuel Standard Act H.R. 2215: Federal Low Carbon Fuels Act H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007 Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Engery and Water Development and Related Agencies Appropriations Act, FY 2008 S. 1751: Energy and Water Development Appropriations Act, FY 2008 H.J. Res 20: Revised Continuing Appropriations Resolution, 2007 Small Business Innovation Research (SBIR) Funding Funding for Stem Cell Research S.5: Stem Cell Research Enhancement Act of 2007
Contacted: Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Treasury, Dept of; SENATE; Small Business Administration (SBA); Office of Science & Technology Policy (OSTP); Centers For Disease Control & Prevention (CDC); Agriculture, Dept of (USDA); Energy, Dept of; State, Dept of (DOS); Securities & Exchange Commission (SEC); White House Office; Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Commerce, Dept of (DOC)
Bills named:
S. 1618 (110th), S. 1297 (110th), S. 1324 (110th), S. 5 (110th), S. 1751 (110th), H.R. 2641 (110th), H.R. 2138 (110th), H.J.Res. 20 (110th), H.R. 2215 (110th), H.R. 6 (110th)
Contacted: Food & Drug Administration (FDA); Small Business Administration (SBA); Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Office of Science & Technology Policy (OSTP); White House Office; Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Office of Management & Budget (OMB); Treasury, Dept of; Energy, Dept of; U.S. Trade Representative (USTR); SENATE; Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Patent & Trademark Office (PTO); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)
FDA Appropriations Critical Path Drug Safety Human Drug Review Funding for Pandemic Influenza FY 2007 Emergency Supplemental Budget FY 2008 Budget H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biodefense Advanced R&D (BARDA) FY 2007 Emergency Supplemental Budget FY 2008 Budget S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for National Institutes of Health S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biotechnology Regulatory Services/USDA FY 2008 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Energy and Water Development and Related Agencies Appropriations Act, FY 2008 S.1751: Energy and Water Development Appropriations Act, FY 2008 H.J.Res 20: Revised Continuing Appropriations Resolution, 2007 Funding for Stem Cell Research S.5: Stem Cell Research Enhancement Act of 2007
Contacted: Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; SENATE; Environmental Protection Agency (EPA); Congressional Budget Office (CBO); Centers For Disease Control & Prevention (CDC); Securities & Exchange Commission (SEC); Energy, Dept of; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); White House Office; U.S. Trade Representative (USTR); State, Dept of (DOS); Commerce, Dept of (DOC); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB)
Bills named:
H.J.Res. 20 (110th), S. 1710 (110th), H.R. 2641 (110th), H.R. 3043 (110th), S. 1751 (110th), S. 5 (110th)
Adventitious Presence Release of USDA's Precursor to APHIS 340 Regs Livestock Cloning Draft FDA Animal Cloning Risk Assessment Proposed FDA Risk Management Plan Draft FDA Guidance for Industry USDA National Organic Standards Board Cloning Recommendation Regulation of Transgenic Animals Development of FDA Guidance and Advance Notice of Proposed Rulemaking Application of Federal Insecticide Fungicide and Rodenticide Act (FIFRA) regulations to biotech plants Drug Importation S.1082: FDA Revitalization Act (FDARA) Drug Safety H.R. 2900: FDA Administration Amendments Act of 2007 (FDAAA) S.1082: FDA Revitalization Act (FDARA)
Contacted: Environmental Protection Agency (EPA); Centers For Disease Control & Prevention (CDC); Energy, Dept of; Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); SENATE; Securities & Exchange Commission (SEC); White House Office; State, Dept of (DOS); Small Business Administration (SBA); Health Resources & Services Administration (HRSA); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Treasury, Dept of; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Congressional Budget Office (CBO); Natl Institutes of Health (NIH)
Bills named:
S. 1082 (110th), H.R. 2900 (110th)
Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Energy and Water Development and Related Agencies Appropriations Act, FY 2008; S. 1751: Energy and Water Development Appropriations Act, FY 2008; H.J. Res 20: Revised Continuing Appropriations Resolution, 2007 Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Engery Conservation Tax Act of 2007 Biorefinery Programs H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007 Renewable Fuels Standard S. 1297: Advanced Clean Fuels Act S. 1324: National Low-Carbon Fuel Standard Act H.R. 2215: Federal Low Carbon Fuels Act H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007
Contacted: Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Small Business Administration (SBA); Health & Human Services, Dept of (HHS); White House Office; State, Dept of (DOS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Energy, Dept of; Natl Institutes of Health (NIH); Treasury, Dept of; Office of Science & Technology Policy (OSTP); Centers For Disease Control & Prevention (CDC); Patent & Trademark Office (PTO); SENATE; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES
Bills named:
H.R. 2215 (110th), S. 1297 (110th), S. 1618 (110th), H.R. 2641 (110th), S. 1324 (110th), H.R. 6 (110th), H.J.Res. 20 (110th), S. 1751 (110th)
Regulation of Transgenic Animals Development of FDA Guidance and Advance Notice of Proposed Rulemaking Livestock Cloning Draft FDA Animal Cloning Risk Assessment Proposed FDA Risk Management Plan Draft FDA Guidance for Industry USDA National Organic Standards Board Cloning Recommendation
Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Treasury, Dept of; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Energy, Dept of; SENATE; Congressional Budget Office (CBO); White House Office; Securities & Exchange Commission (SEC)
340B of the Public Health Service Act/Drug Prices for Covered Entities Administrative Interpretations of Pricing Calculations Guidance on Calculation of 340B Ceiling Price Medicaid Expansion/Rebates H.R. 3162: The Children's Health and Medicare Protection Act of 2007 S.1893: The Children's Health Insurance Program Reauthorization Act of 2007 Medicare Part D "Non-Interference" Proposals S.250 and H.R. 4: Medicare Prescription Drug Price Negotiation Act
Contacted: White House Office; Patent & Trademark Office (PTO); Energy, Dept of; Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); Environmental Protection Agency (EPA); Small Business Administration (SBA); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Treasury, Dept of; Natl Institutes of Health (NIH); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE
Bills named:
H.R. 3162 (110th), H.R. 4 (110th), S. 1893 (110th), S. 250 (110th)
Cellulosic Ethanol Tax Credit S. 1618: To amend the Internal Revenue Code of 1986 to provide a credit for the production of cellulosic biofuel S.Amdt. 1704: To amend the Internal Revenue Code of 1986 to provide for energy advancement and investment, and for other purposes H..R. 2776: Renewable Energy and Engery Conservation Tax Act of 2007 Renewable Fuels Standard S. 1297: Advanced Clean Fuels Act S. 1324: National Low-Carbon Fuel Standard Act H.R. 2215: Federal Low Carbon Fuels Act H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007 Biorefinery Programs H.R. 6: Renewable Fuels, Consumer Protection, and Energy Efficiency Act of 2007 Biorefinery Funding/Cellulosic Ethanol Funding H.R. 2641: Engery and Water Development and Related Agencies Appropriations Act, FY 2008; S. 1751: Energy and Water Development Appropriations Act, FY 2008; H.J.Res 20: Revised Continuing Appropriations Resolution, 2007
Contacted: Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); White House Office; Health & Human Services, Dept of (HHS); SENATE; Agriculture, Dept of (USDA); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Small Business Administration (SBA); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Energy, Dept of; State, Dept of (DOS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO)
Bills named:
S. 1324 (110th), S. 1297 (110th), H.R. 2641 (110th), S. 1618 (110th), H.R. 6 (110th), S. 1751 (110th), H.J.Res. 20 (110th), H.R. 2215 (110th)
Biodefense Implementation Plan and Strategic Plan HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Funding for Pandemic Influenza FY 2007 Emergency Supplemental Budget FY 2008 Budget H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biodefense Advanced R&D (BARDA) FY 2007 Emergency Supplemental Budget FY 2008 Budget S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008
Contacted: Small Business Administration (SBA); Patent & Trademark Office (PTO); Congressional Budget Office (CBO); Energy, Dept of; SENATE; State, Dept of (DOS); Agriculture, Dept of (USDA); Treasury, Dept of; Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); White House Office; Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)
Bills named:
H.R. 3043 (110th), S. 1710 (110th)
R&D Tax Credits H.R. 2138: Investment in America Act of 2007 Funding for Pandemic Influenza FY 2007 Emergency Supplemental Budget FY 2008 Budget H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Biodefense Advanced R&D (BARDA) FY 2007 Emergency Supplemental Budget FY 2008 Budget S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for National Institutes of Health S. 1710: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 H.R. 3043: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2008 Funding for Stem Cell Research S.5: Stem Cell Research Enhancement Act of 2007 FDA Appropriations Critical Path Drug Safety Human Drug Review Genetic Information Nondiscrimination S. 358 H.R. 493
Contacted: White House Office; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); State, Dept of (DOS); Small Business Administration (SBA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); SENATE; Securities & Exchange Commission (SEC); Centers For Disease Control & Prevention (CDC); Agriculture, Dept of (USDA); Treasury, Dept of; Food & Drug Administration (FDA); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Energy, Dept of
Bills named:
S. 1710 (110th), H.R. 3043 (110th), S. 5 (110th), S. 358 (110th), H.R. 2138 (110th), H.R. 493 (110th)
Shown as published by the Senate Office of Public Records and the House Clerk under the
Lobbying Disclosure Act. The official filing is the record; open it for the full form.